Brokerages expect Oak Street Health, Inc. (NYSE:OSH) to post $282.44 million in sales for the current quarter, according to Zacks. Four analysts have provided estimates for Oak Street Health’s earnings, with estimates ranging from $280.50 million to $283.62 million. The business is expected to announce its next quarterly earnings results on Tuesday, June 8th.

According to Zacks, analysts expect that Oak Street Health will report full year sales of $1.31 billion for the current financial year, with estimates ranging from $1.30 billion to $1.34 billion. For the next financial year, analysts anticipate that the business will report sales of $2.07 billion, with estimates ranging from $1.98 billion to $2.19 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Oak Street Health.

Oak Street Health (NYSE:OSH) last released its quarterly earnings results on Monday, March 8th. The company reported ($0.40) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.25) by ($0.15). The business had revenue of $248.70 million for the quarter, compared to analyst estimates of $231.79 million. The firm’s revenue for the quarter was up 43.3% compared to the same quarter last year.

Several research firms have recently issued reports on OSH. Truist upped their price objective on shares of Oak Street Health from $60.00 to $72.00 in a report on Friday, December 18th. Wolfe Research began coverage on shares of Oak Street Health in a report on Thursday, January 28th. They set an “outperform” rating and a $62.00 price objective on the stock. Canaccord Genuity began coverage on shares of Oak Street Health in a report on Tuesday, March 2nd. They set a “buy” rating and a $67.00 price objective on the stock. Morgan Stanley upped their price objective on shares of Oak Street Health from $73.00 to $79.00 and gave the company an “overweight” rating in a report on Thursday, March 18th. Finally, Piper Sandler upped their price objective on shares of Oak Street Health from $59.00 to $69.00 in a report on Wednesday, February 17th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and twelve have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $66.92.

In other news, insider Robert Guenthner sold 5,902 shares of the firm’s stock in a transaction that occurred on Thursday, February 25th. The shares were sold at an average price of $55.82, for a total transaction of $329,449.64. Following the sale, the insider now owns 560,524 shares of the company’s stock, valued at approximately $31,288,449.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director General Atlantic Llc sold 7,429,453 shares of the firm’s stock in a transaction that occurred on Tuesday, February 16th. The stock was sold at an average price of $54.18, for a total transaction of $402,527,763.54. The disclosure for this sale can be found here. Insiders have sold a total of 7,453,061 shares of company stock worth $403,833,758 in the last ninety days. Corporate insiders own 5.66% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of OSH. HM Payson & Co. acquired a new stake in shares of Oak Street Health during the 3rd quarter worth approximately $29,000. Arkadios Wealth Advisors purchased a new position in shares of Oak Street Health during the 4th quarter valued at approximately $121,000. Sowell Financial Services LLC lifted its position in shares of Oak Street Health by 69.9% during the 4th quarter. Sowell Financial Services LLC now owns 2,443 shares of the company’s stock valued at $149,000 after buying an additional 1,005 shares in the last quarter. Raymond James Financial Services Advisors Inc. purchased a new position in shares of Oak Street Health during the 4th quarter valued at approximately $217,000. Finally, Jane Street Group LLC purchased a new position in shares of Oak Street Health during the 3rd quarter valued at approximately $238,000. 66.59% of the stock is currently owned by institutional investors and hedge funds.

Shares of OSH traded up $2.51 during mid-day trading on Monday, hitting $62.40. 17,183 shares of the company traded hands, compared to its average volume of 1,301,177. Oak Street Health has a 1-year low of $37.11 and a 1-year high of $66.31. The business has a 50 day moving average of $55.80 and a 200 day moving average of $53.96.

About Oak Street Health

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.

Further Reading: What is the return on assets (ROA) ratio?

Get a free copy of the Zacks research report on Oak Street Health (OSH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.